"10.1371_journal.pone.0098371","plos one","2014-06-04T00:00:00Z","Thibaut Caruba; Sandrine Katsahian; Catherine Schramm; Ana√Øs Charles Nelson; Pierre Durieux; Dominique B√©gu√©; Yves Juilli√®re; Olivier Dubourg; Nicolas Danchin; Brigitte Sabatier","Pharmacie, H√¥pital Europ√©en Georges Pompidou, APHP, Paris, France; URC H√¥pital Henri Mondor, APHP, Cr√©teil, France; Equipe 22, Centre de Recherche des Cordeliers, UMRS 762 INSERM, Paris, France; D√©partement de Sant√© Publique et Informatique, H√¥pital Europ√©en Georges Pompidou, APHP, Paris, France; Facult√© de Pharmacie, Universit√© Ren√© Descartes, Paris, France; Cardiologie, Institut Lorrain du C≈ur et des Vaisseaux Louis Mathieu, Nancy, France; Cardiologie, H√¥pital Ambroise Par√©, APHP, Boulogne Billancourt, France; Universit√© de Versailles-Saint Quentin, Montigny-Le-Bretonneux, France; Cardiologie, H√¥pital Europ√©en Georges Pompidou, APHP, Paris, France; Facult√© de M√©decine, Universit√© Ren√© Descartes, Paris, France","Conceived and designed the experiments: TC BS PD DB ND. Performed the experiments: TC BS PD ND. Analyzed the data: SK CS ACN. Wrote the paper: TC BS SK PD OD YJ ND.","The authors have read the journals policy. Three co-authors have the following conflicts: 1) Pr Dubourg: consultancy: Bracco Altam Pharma; and grant: Sorin France and Medtronic. 2) Pr Juilli√®re: consultancy: Abbott vascular, AstraZeneca, Bayer, Bristol-Myers-Squibb, MSD-Schering, Novartis, Sanofi Aventis and Servier; and grant: AstraZeneca. 3) Pr Danchin: board membership: AstraZeneca, Bayer, Daiichi-Sankyo, Eli-Lilly, Novo-nordisk and Servier; consultancy: GSK and Sanofi Aventis; and grant: MSD, AstraZeneca, Daiichi-Sankyo, Eli-Lilly, GSK, Novartis and Sanofi Aventis. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2014","06","Thibaut Caruba","TC",10,TRUE,5,4,3,7,TRUE,FALSE,FALSE,0,NA,FALSE
